Literature DB >> 17630702

Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Rustem I Litvinov1, Sergiy Yakovlev, Galina Tsurupa, Oleg V Gorkun, Leonid Medved, John W Weisel.   

Abstract

The carboxyl-terminal regions of the fibrinogen Aalpha chains (alphaC regions) form compact alphaC-domains tethered to the bulk of the molecule with flexible alphaC-connectors. It was hypothesized that in fibrinogen two alphaC-domains interact intramolecularly with each other and with the central E region preferentially through its N-termini of Bbeta chains and that removal of fibrinopeptides A and B upon fibrin assembly results in dissociation of the alphaC regions and their switch to intermolecular interactions. To test this hypothesis, we studied the interactions of the recombinant alphaC region (Aalpha221-610 fragment) and its subfragments, alphaC-connector (Aalpha221-391) and alphaC-domain (Aalpha392-610), between each other and with the recombinant (Bbeta1-66)2 and (beta15-66)2 fragments and NDSK corresponding to the fibrin(ogen) central E region, using laser tweezers-based force spectroscopy. The alphaC-domain, but not the alphaC-connector, bound to NDSK, which contains fibrinopeptides A and B, and less frequently to desA-NDSK and (Bbeta1-66)2 containing only fibrinopeptides B; it was poorly reactive with desAB-NDSK and (beta15-66)2 both lacking fibrinopeptide B. The interactions of the alphaC-domains with each other and with the alphaC-connector were also observed, although they were weaker and heterogeneous in strength. These results provide the first direct evidence for the interaction between the alphaC-domains and the central E region through fibrinopeptide B, in agreement with the hypothesis given above, and indicate that fibrinopeptide A is also involved. They also confirm the hypothesized homomeric interactions between the alphaC-domains and display their interaction with the alphaC-connectors, which may contribute to covalent cross-linking of alpha polymers in fibrin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630702      PMCID: PMC2678904          DOI: 10.1021/bi700944j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  64 in total

1.  Congenital afibrinogenaemia in a newborn infant due to a novel mutation in the fibrinogen aalpha gene.

Authors:  José J Vlietman; Jan Verhage; Hans L Vos; Richard van Wijk; Jasper A Remijn; Wouter W van Solinge; Frank Brus
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

2.  Involvement of the alpha chain in fibrin clot formation. Effect of monoclonal antibodies.

Authors:  C S Cierniewski; A Z Budzynski
Journal:  Biochemistry       Date:  1992-05-05       Impact factor: 3.162

3.  Interactions mediated by the N-terminus of fibrinogen's Bbeta chain.

Authors:  Oleg V Gorkun; Rustem I Litvinov; Yuri I Veklich; John W Weisel
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

4.  Overstretching B-DNA: the elastic response of individual double-stranded and single-stranded DNA molecules.

Authors:  S B Smith; Y Cui; C Bustamante
Journal:  Science       Date:  1996-02-09       Impact factor: 47.728

5.  Disulfide bridges in nh2 -terminal part of human fibrinogen.

Authors:  B Blombäck; B Hessel; D Hogg
Journal:  Thromb Res       Date:  1976-05       Impact factor: 3.944

6.  Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains.

Authors:  Sergei Gorlatov; Leonid Medved
Journal:  Biochemistry       Date:  2002-03-26       Impact factor: 3.162

Review 7.  Fibrinogen and fibrin.

Authors:  R F Doolittle
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

8.  Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin.

Authors:  S D Lewis; P P Shields; J A Shafer
Journal:  J Biol Chem       Date:  1985-08-25       Impact factor: 5.157

9.  Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA).

Authors:  J Koopman; F Haverkate; J Grimbergen; R Egbring; S T Lord
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

10.  Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen.

Authors:  Y V Matsuka; L V Medved; M M Migliorini; K C Ingham
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

View more
  40 in total

1.  Substitution of the human αC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers.

Authors:  Lifang Ping; Lihong Huang; Barbara Cardinali; Aldo Profumo; Oleg V Gorkun; Susan T Lord
Journal:  Biochemistry       Date:  2011-09-27       Impact factor: 3.162

2.  α-α Cross-links increase fibrin fiber elasticity and stiffness.

Authors:  Christine C Helms; Robert A S Ariëns; S Uitte de Willige; Kristina F Standeven; Martin Guthold
Journal:  Biophys J       Date:  2012-01-03       Impact factor: 4.033

3.  Structural hierarchy governs fibrin gel mechanics.

Authors:  Izabela K Piechocka; Rommel G Bacabac; Max Potters; Fred C Mackintosh; Gijsje H Koenderink
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

4.  Evidence that αC region is origin of low modulus, high extensibility, and strain stiffening in fibrin fibers.

Authors:  John R Houser; Nathan E Hudson; Lifang Ping; E Timothy O'Brien; Richard Superfine; Susan T Lord; Michael R Falvo
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

5.  Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.

Authors:  Radwa H Abou-Saleh; Simon D Connell; Robert Harrand; Ramzi A Ajjan; Michael W Mosesson; D Alastair M Smith; Peter J Grant; Robert A S Ariëns
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

6.  Engineering fibrin polymers through engagement of alternative polymerization mechanisms.

Authors:  Sarah E Stabenfeldt; Merek Gourley; Laxminarayanan Krishnan; James B Hoying; Thomas H Barker
Journal:  Biomaterials       Date:  2011-10-21       Impact factor: 12.479

7.  Fibrinogen variant BbetaD432A has normal polymerization but does not bind knob "B".

Authors:  Sheryl R Bowley; Susan T Lord
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

8.  Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.

Authors:  Rustem I Litvinov; Serge V Yarovoi; Lubica Rauova; Valeri Barsegov; Bruce S Sachais; Ann H Rux; Jillian L Hinds; Gowthami M Arepally; Douglas B Cines; John W Weisel
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

9.  The mechanical properties of single fibrin fibers.

Authors:  W Liu; C R Carlisle; E A Sparks; M Guthold
Journal:  J Thromb Haemost       Date:  2010-01-17       Impact factor: 5.824

10.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.